Mylan CEO Defends EpiPen Price Hike to Lawmakers

Mylan Pharmaceuticals CEO Heather Bresch defended her company's decision to increase the price of the EpiPen during a hearing held by the House Committee on Oversight and Government Reform this afternoon.

September 21, 2016

Examined